The Promise of Personalized Medicine

Clinical Utility and Personalized Medicine w/ Dr. Charles Stemple

September 27, 2022 Perry Dimas Season 1 Episode 2
Clinical Utility and Personalized Medicine w/ Dr. Charles Stemple
The Promise of Personalized Medicine
More Info
The Promise of Personalized Medicine
Clinical Utility and Personalized Medicine w/ Dr. Charles Stemple
Sep 27, 2022 Season 1 Episode 2
Perry Dimas

With the explosion of popularity with personalized medicine in the last decade, the need for clearly defined clinical utility is ever growing. It’s not enough to have the proof that a test works–but what treatment can Doctors and patients then take with those results? 


This question is explored with today's guest, Dr. Charles Stemple, former Humana Medical Director. His insights on clinical utility and the need for intention within the tests are impeccable. 


Join us as we discuss:

  • The need for clearly defined tests and how they will change the treatments for patients
  • The importance of a SWOT analysis on developing tests
  • Developing the intention for the tests in the marketplace
  • The economic impact of the tests 



—------------

Stay connected with our host, Perry Dimas, here on LinkedIn


Show Notes

With the explosion of popularity with personalized medicine in the last decade, the need for clearly defined clinical utility is ever growing. It’s not enough to have the proof that a test works–but what treatment can Doctors and patients then take with those results? 


This question is explored with today's guest, Dr. Charles Stemple, former Humana Medical Director. His insights on clinical utility and the need for intention within the tests are impeccable. 


Join us as we discuss:

  • The need for clearly defined tests and how they will change the treatments for patients
  • The importance of a SWOT analysis on developing tests
  • Developing the intention for the tests in the marketplace
  • The economic impact of the tests 



—------------

Stay connected with our host, Perry Dimas, here on LinkedIn